Market Cap

CK Life Sciences Int'l., (Holdings), Inc. Market Capitalization:

€404.8 Million

EUR as of July 1, 2024

US$434.8 Million

business CK Life Sciences Int'l., (Holdings), Inc. Company Profile

CK Life Sciences Int'l., (Holdings), Inc. Main Stock Listing

FSX: LSI

Market Capitalization History of CK Life Sciences Int'l., (Holdings), Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of CK Life Sciences Int'l., (Holdings), Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 €697.0 M -21.25%
Jan. 1, 2023 €885.1 M 14.94%
Jan. 1, 2022 €770.1 M -13.48%
Jan. 1, 2021 €890.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

CK Life Sciences Int'l., (Holdings), Inc. Categories

Hong Kong languages Healthcare languages Biotechnology
Hong Kong Healthcare Hong Kong Biotechnology

Stocks & Indices

CK Life Sciences Int'l., (Holdings), Inc. has the following listings and related stock indices.


Stock: FSX: LSI

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.